StockData
vTv Therapeutics Inc. logo

vTv Therapeutics Inc. (VTVT) stock

VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3062% below fair value
$17.29−0.40 (-2.26%)

Close on Nov 17, 2026Market cap $68.37MP/E –Yield –

vTv Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

vTv Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -12.9%. For fiscal 2024 it was -1815.3%, against -949.7% the year before. The highest annual figure on record is -63.6% in fiscal 2018.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-1815.3%−865.7
FY2022Dec 31, 2022-949.7%−625.4
FY2021Dec 31, 2021-324.3%−191.8
FY2020Dec 31, 2020-132.5%+339.4
FY2019Dec 31, 2019-471.9%−408.3
FY2018Dec 31, 2018-63.6%+5484.1
FY2017Dec 31, 2017-5547.8%−2968.6
FY2016Dec 31, 2016-2579.2%+2719.1
FY2015Dec 31, 2015-5298.3%−2967.7
FY2014Dec 31, 2014-2330.6%+2608.2
FY2013Dec 31, 2013-4938.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 202665.5%+35076.6
Q4 FY2024Dec 31, 2024-21376.5%−21026.1
Q1 FY2024Mar 31, 2024-486.5%+77857.9
Q4 FY2022Dec 31, 2022-52722.2%−52686.0
Q2 FY2022Jun 30, 2022-35011.1%−28255.6
Q1 FY2022Mar 31, 2022-350.3%+79.3
Q4 FY2021Dec 31, 2021-78344.4%−78362.0
Q3 FY2021Sep 30, 2021-36.2%+21863.8
Q2 FY2021Jun 30, 2021-6755.6%+52294.4
Q1 FY2021Mar 31, 2021-429.7%+62413.2
Q4 FY2020Dec 31, 202017.6%+45117.6
Q3 FY2020Sep 30, 2020-21900.0%−21742.3
Q1 FY2020Mar 31, 2020-59050.0%−58816.0
Q4 FY2019Dec 31, 2019-62842.9%−62818.7
Q3 FY2019Sep 30, 2019-45100.0%−45076.4
Q2 FY2019Jun 30, 2019-157.7%−33.4
Q1 FY2019Mar 31, 2019-234.0%−91.0
Q4 FY2018Dec 31, 2018-24.1%+1826.1
Q3 FY2018Sep 30, 2018-23.6%+24309.7
Q2 FY2018Jun 30, 2018-124.2%+30360.4
Q1 FY2018Mar 31, 2018-143.0%+13923.6
Q4 FY2017Dec 31, 2017-1850.2%+8807.7
Q3 FY2017Sep 30, 2017-24333.3%−13825.4
Q2 FY2017Jun 30, 2017-30484.6%–
Q1 FY2017Mar 31, 2017-14066.7%–
Q4 FY2016Dec 31, 2016-10657.9%–
Q3 FY2016Sep 30, 2016-10507.9%–

More vTv Therapeutics figures

See a number that looks wrong?